25 Best Dividend Aristocrats to Buy According to Analysts
The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm.
West Pharmaceutical Services Inc (WST)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 1,060,146 | $419,510,374 | +15% | 0.08% |
| 2. | Durable Capital Partners Henry Ellenbogen | 1,031,053 | $407,997,983 | -10% | 3.16% |
| 3. | Millennium Management Israel Englander | 516,626 | $204,434,074 | +1864% | 0.08% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 375,678 | $148,659,541 | +495% | 0.22% |
| 5. | Holocene Advisors Brandon Haley | 357,008 | $141,271,636 | 0.51% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $105.14 | 54 | 66,251 | 2019-02-28 | Filing | ||
| $110.55 | 57 | 66,197 | 2018-07-31 | Filing | ||
| $93.94 | 335 | 66,475 | 2017-10-17 | Filing | ||
| $88.89 | 275 | 56,540 | 2018-05-15 | Filing | ||
| $84.53 | 332 | 51,831 | 2016-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $330.78 | 1,800 | Officer | 2,860 | 2024-06-12 | Filing | |
| $366.65 | 41,000 | Officer, Director | 152,908 | 2024-05-07 | Filing | |
| $366.66 | 15,684 | Officer, Director | 193,908 | 2024-05-07 | Filing | |
| $366.64 | 9,316 | Officer, Director | 209,952 | 2024-05-07 | Filing | |
| $358.82 | 815 | Officer | 1,309 | 2024-03-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,002,632 | $3,170,006,779 | 0.06% | |
| 2. | 7,778,305 | $2,738,896,586 | 0.06% | |
| 3. | 3,331,553 | $1,173,106,497 | 0.23% | |
| 4. | 3,271,929 | $1,152,111,639 | 0.05% | |
| 5. | 2,105,589 | $741,420,002 | 0.34% |
News See All
Here’s Why West Pharmaceutical Services (WST) Bounced Back in Q1
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. beats earnings expectations. Reported EPS is $1.56, expectations were $1.26. West Pharmaceutical Services, Inc.
What Makes West Pharmaceutical Services (WST) an Attractive Bet?
ClearBridge Investments, an investment management firm, released its fourth-quarter 2023 “Mid Cap Growth Strategy” investor letter, a copy of which can be downloaded here.
5 Most Reliable Dividend Stocks To Buy
In this article, we discuss 5 most reliable dividend stocks to buy.
West Pharmaceutical Services (WST) Fell on Reduced Full Year Guidance
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2023 Earnings Call Transcript
West Pharmaceutical Services, Inc. beats earnings expectations. Reported EPS is $1.83, expectations were $1.78. West Pharmaceutical Services, Inc.
Ken Griffin's Wellington Fund Delivers Mind-Numbing Returns: Here are Its Top 15 Stocks
In this article, we will explore Ken Griffin's Wellington Fund delivers mind-numbing returns and its top 15 stocks.
Here’s Why West Pharmaceutical Services (WST) Fell in Q4
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
